Related Experiment Video
Updated: Sep 10, 2025

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
Published on: October 6, 2015
Risk factors and mortality rates for children co-infected with HIV and TB in Ethiopia: a systematic review and
Fassikaw Kebede Bizuneh1, Tsehay Kebede Bizuneh2, Biruk Beletew Abate3
1College of Medicine and Health Science, Debre Markos University, P.O. Box 269, Ethiopia.
Abstract:
This systematic review and meta-analysis aimed to identify risk factors and mortality rates in HIV and TB co-infected children in Ethiopia. An electronic literature search was conducted using multiple databases, including PubMed, Medline, Web of Science, African Journal Online, Google Scholar and university research repositories for gray literature. Weighted inverse variance random-effects meta-regression was employed to calculate pooled mortality rates, utilizing Stata/SE-17 for analysis. The meta-analysis included six eligible studies, encompassing a total of 2025 co-infected children. Among these, 238 deaths were reported over 1670.6 person-years. This made the crude mortality rate 11.74% (95% CI 11.49 to 16.12%) with an incidence of 1.5 deaths (95% CI 1.17 to 1.89) per 100 person-years. Factors including WHO stages III and IV (4.34, 95% CI 2.25 to 8.36), poor antiretroviral therapy (ART) adherence (3.11, 95% CI 2.04 to 4.15), missed isoniazid preventive therapy (IPT) (3.07, 95% CI 1.52 to 6.23) and low hemoglobin levels of ≤10 mg/dl (2.84, 95% CI 2.02 to 3.99) were predictors compared with their counterparts.This review reveals an unacceptably high pooled incidence of mortality among HIV and TB co-infected children in Ethiopia. Therefore, implementing systematic screenings for IPT, enhancing ART adherence counseling and addressing anemia through early treatment are critical for preventing premature deaths. Protocol registration in Prospero = CRD42024502038.
More Related Videos
09:02An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
Published on: February 17, 2014
08:10A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb BCG lux/M.Tb lux
Published on: September 14, 2011
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: